Results 271 to 280 of about 68,610 (290)

The orphan drug pipeline in Europe

Nature Reviews Drug Discovery, 2016
Thomas Morel, Bruno Sepodes, David Cassiman   +2 more
exaly  

Are orphan drug companies the pick of the pharmaceutical industry?

Nature Reviews Drug Discovery, 2013
Thomas Morel, Steven R A Simoens
exaly  

Evergreening exclusive rights in pharmaceutical products: the case of SPCs, paediatric extensions and orphan drugs

2022
openaire   +1 more source

The Committee for Orphan Medicinal Products of the European Medicines Agency has granted PTC 124 [PTC Therapeutics] orphan drug status

Inpharma Weekly, 2005
openaire   +1 more source

Emergence of orphan drugs in the United States: a quantitative assessment of the first 25 years

Nature Reviews Drug Discovery, 2010
exaly  

1989 annual survey--133 orphan drug products.

Hospital pharmacy, 1990
openaire   +1 more source

Rare diseases, orphan drugs and their regulation: questions and misconceptions

Nature Reviews Drug Discovery, 2010
exaly  

The Committee for Orphan Medical Products of the EMEA has adopted a positive opinion recommending orphan drug designation for PI-88

Inpharma Weekly, 2007
openaire   +1 more source

Orphan drug development in China: progress and challenges

Lancet, The, 2019
Shuyang Zhang, Limeng Chen, Yupei Zhao
exaly  

Ensuring Effectiveness, Safety, and Access to Orphan Drug Products (1821)

2019
openaire   +1 more source